Know Cancer

or
forgot password
  • cancer clinical trials in new york, NY

  • Biaxin Based Antibiotic Therapy in Previously Untreated, Advanced Stage Indolent Lymphoma
    Memorial Sloan-Kettering Cancer Center
    New York, New York 10021
    Lymphoma
    Combination Chemotherapy in Treating Young Patients With Relapsed or Refractory Acute Leukemia
    Memorial Sloan-Kettering Cancer Center
    New York, New York 10021
    Leukemia
    Sutent and Radiation as Treatment for Limited Extent Metastatic Cancer
    Mount Sinai School of Medicine
    New York, New York 10029
    Cancer
    A Phase II Study of Pomalidomide in Myelofibrosis With Myeloid Metaplasia
    Memorial Sloan-Kettering Cancer Center

    Trial Locations
    Memorial Sloan-Kettering Cancer Center
    New York Presbyterian HospitalWeill Medical College of Cornell University
    Myelofibrosis With Myeloid Metaplasia, Myeloid Metaplasia, Myelofibrosis
    Combination Chemotherapy in Treating Young Patients With Recurrent or Resistant Malignant Germ Cell Tumors
    Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center
    New York, New York 10032
    Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor, Ovarian Cancer, Testicular Germ Cell Tumor
    Bicalutamide in Treating Patients With Metastatic Breast Cancer
    Memorial Sloan-Kettering Cancer Center

    Trial Locations
    Memorial Sloan-Kettering Cancer Center
    Ralph Lauren Center for Cancer Care and Prevention
    Breast Cancer
    Efficacy and Safety Study of StemEx®, to Treat Subjects With High Risk Hematologic Malignancies, Following Myeloablative Therapy
    Cornell University, Joan & Sanford I. Weill Medical College
    New York, New York NY 10065
    Hematologic Malignancies, Acute Myeloid Leukemia, Lymphoid Leukemia, Chronic Myeloid Leukemia, Hodgkin's Disease, Non-Hodgkin's Lymphoma, Myelodysplastic Syndromes
    Tipifarnib and Combination Chemotherapy in Treating Patients With Stage II or Stage III Breast Cancer
    Weill Medical College of Cornell University

    Trial Locations
    Weill Medical College of Cornell University
    Mount Sinai Medical Center
    Columbia University Medical Center
    Breast Cancer, Male Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer
    Imatinib Mesylate in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery
    Mount Sinai Medical Center
    New York, New York 10029
    Acral Lentiginous Malignant Melanoma, Recurrent Melanoma, Stage IIIA Melanoma, Stage IIIB Melanoma, Stage IIIC Melanoma, Stage IV Melanoma
    Vaccine Therapy and QS21 in Treating Patients With Metastatic Breast Cancer
    Memorial Sloan-Kettering Cancer Center
    New York, New York 10021
    Breast Cancer
    Prostate Cancer Study In Men Who Have Failed First-Line Androgen Deprivation Therapy
    GSK Investigational Site
    New York, New York 10021
    Neoplasms, Prostate, Prostate Cancer
    A Study of Imatinib Versus Nilotinib in Adult Patients With Newly Diagnosed Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP)
    Memorial Sloan Kettering Cancer Center Clinical Trials Office
    New York, New York 10021
    Myelogenous Leukemia, Chronic
    Development of a Questionnaire to Evaluate Patient Expectations for Breast Reconstruction in Women With Breast Cancer or Other Conditions
    Memorial Sloan-Kettering Cancer Center

    Trial Locations
    Memorial Sloan-Kettering Cancer Center
    New School for Social Research
    Breast Cancer
    ALL Adult Consortium Trial: Adult ALL Trial
    Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center
    New York, New York 10032
    Acute Lymphoblastic Leukemia
    Assessment Tool for Older Patients With Cancer
    Memorial Sloan-Kettering Cancer Center
    New York, New York 10021
    Cognitive/Functional Effects, Psychosocial Effects of Cancer and Its Treatment, Unspecified Adult Solid Tumor, Protocol Specific
    GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Non-Small Cell Lung Cancer
    GSK Investigational Site
    New York, New York 10021
    Lung Cancer, Non-Small Cell
    Study to Evaluate Immune Responses in Neurologically Normal Cancer Patients
    Rockefeller University Hospital
    New York, New York 10021-6399
    Healthy
    Platinum for Triple-Negative Metastatic Breast Cancer and Evaluation of p63/p73 as a Biomarker of Response
    Memorial Sloan Kettering Cancer Center
    New York, New York 10021
    Breast Cancer
    Management of Atypical Endometrial Hyperplasia and Endometrial Carcinoma Using Megestrol Acetate
    Bellevue Hospital

    Trial Locations
    Bellevue Hospital
    NYU Cancer Center
    Atypical Endometrial Hyperplasia, Endometrial Carcinoma
    Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
    New York Weill Cornell Cancer Center at Cornell University
    New York, New York 10021
    Neurotoxicity Syndromes, Pain, Peripheral Neuropathy, Unspecified Adult Solid Tumor, Protocol Specific
    Phase II Lapatinib and Radiation for Stage III-IV Head and Neck Cancer Patients Who Cannot Tolerate Concurrent Chemotherapy
    Beth Israel
    New York, New York 10003
    Head and Neck Cancer, Carcinoma, Squamous Cell, Head and Neck Cancers
    ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063D
    GSK Investigational Site
    New York, New York 10021
    Neoplasms, Breast, Breast Cancer
    Beta-Glucan and Monoclonal Antibody 3F8 in Treating Patients With Metastatic Neuroblastoma
    Memorial Sloan-Kettering Cancer Center
    New York, New York 10021
    Neuroblastoma
    1st or 2nd Line MBC (Metastatic Breast Cancer) With Previous Avastin (Bevacizumab) Therapy
    Memorial Sloan-Kettering Cancer Center
    New York, New York 10021
    Breast Cancer
    Adj TC + Herceptin Early Stage Breast Cancer
    Ruth Oratz MD
    New York, New York 10016
    Breast Cancer
    Randomized Controlled Trial of Group Psychotherapy Interventions for Cancer Patients
    Memorial Sloan-Kettering Cancer Center 1275 York Avenue
    New York, New York 10021
    Palliative Care
    Chemotherapy-Induced Changes to Cognition and DNA in Breast Cancer Survivors
    Memorial Sloan-Kettering Cancer Center 1275 York Avenue
    New York, New York 10021
    Breast Cancer, Long-Term Survivors
    Temozolomide in Treating Patients With Recurrent Glioblastoma Multiforme or Other Malignant Glioma
    Memorial Sloan-Kettering Cancer Center
    New York, New York 10021
    Brain and Central Nervous System Tumors
    Comparison of Different Types of Surgery in Treating Patients With Stage IA Non-Small Cell Lung Cancer
    New York Weill Cornell Cancer Center at Cornell University
    New York, New York 10021
    Lung Cancer
    Combination Chemotherapy and Surgery With or Without Isotretinoin in Treating Young Patients With Neuroblastoma
    NYU Cancer Institute at New York University Medical Center

    Trial Locations
    NYU Cancer Institute at New York University Medical Center
    Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center
    Neuroblastoma
    Topical Imiquimod in Treating Patients With Recurrent Paget's Disease of the Vulva
    Memorial Sloan-Kettering Cancer Center
    New York, New York 10021
    Vulvar Cancer
    Phase II Study of "VIPER" Chemotherapy in Rel/Ref DLBCL
    Weill Cornell Medical College
    New York, New York 10021
    Non-Hodgkin's Lymphoma
    Phase I Trial of Anti-CD74 (hLL1) Antibody Therapy in B Cell Malignancies
    Weill Cornell Medical College
    New York, New York 10021
    Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia
    Prospective Trial of Vaccine Responses in Childhood Cancer Survivors
    Memorial Sloan-Kettering Cancer Center 1275 York Avenue
    New York, New York 10021
    Childhood Cancer, Multiple Diseases
    Randomized Phase 3b Study in Previously Untreated Multiple Myeloma Patients: VELCADE,Thalidomide, and Dexamethasone Versus VELCADE and Dexamethasone Versus VELCADE, Melphalan, and Prednisone
    Memorial Sloan Kettering Cancer Center

    Trial Locations
    Memorial Sloan Kettering Cancer Center
    New York Presbyterian Hospital-Cornell Campus
    Multiple Myeloma
    A Phase 1 Study of MDV3100 in Patients With Castration-Resistant (Hormone-Refractory) Prostate Cancer
    Memorial Sloan-Kettering Cancer Center
    New York, New York 10021
    Prostate Cancer, Hormone Refractory Prostate Cancer
    IGIV Study for Chronic ITP Patients Ages 3-70
    Mt. Sinai Medical Center
    New York, New York 10029
    Idiopathic Thrombocytopenic Purpura
    Phase 2 Study of Carfilzomib in Relapsed and Refractory Multiple Myeloma
    St. Vincent Catholic Medical Center
    New York, New York 10011
    Multiple Myeloma
    Early or Delayed Fludarabine and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia
    New York Weill Cornell Cancer Center at Cornell University
    New York, New York 10021
    Leukemia
    Risk Factors for Endometrial Cancer in Black Women
    Memorial Sloan-Kettering Cancer Center

    Trial Locations
    Memorial Sloan-Kettering Cancer Center
    City College of New York
    Endometrial Cancer
    Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma
    Weill Medical College of Cornell University

    Trial Locations
    Weill Medical College of Cornell University
    Memorial Sloan-Kettering Cancer Center 1275 York Avenue
    Gastroesophageal Junction Adenocarcinoma, Gastric Cancer
    Health Behaviors, Surveillance, Psychosocial Factors, and Family Concerns
    Memorial Sloan-Kettering Cancer Center 1275 York Avenue
    New York, New York 10021
    Melanoma, Survivors, Psychological Factors
    In Vitro Fertilization After Use of Chemotherapy
    IFP
    New York, New York 10595
    Cancer